CIK 0001835022 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Coya Therapeutics, Inc.
Sign in to watch- Ticker
- COYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650.739.3939
- Business address
- 12645 MEMORIAL DR., SUITE F1 #305, HOUSTON, TX, 77024
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 4/A Insider Changes in Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 10,000 shares
- 4 Open-market buy Director bought 10,000 shares
- 4 Open-market buy Chief Medical Officer bought 10,000 shares
- 4 Open-market buy Director bought 2,000 shares
- 4 Open-market buy Chief Financial Officer bought 7,000 shares
- 4 Open-market buy Director bought 10,000 shares
- 4 Open-market buy Director bought 10,000 shares
- 424B4 Offering Prospectus
- CERT Other Certification
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
Page 10 of 12 · 232 filings